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Introduction
Acute infectious mononucleosis (IM) is mostly caused by a
widespread human γ-herpes virus, the Epstein-Barr virus (EBV) or a
human β-herpes virus, the cytomegalovirus (CMV). Primary infection
appears predominantly in children, adolescents and young adults [1].
Symptoms start with a prodromal phase including subfebrility,
malaise, arthralgia and myalgia, similar to other common upper
respiratory tract infections [2,3]. After the prodromal symptoms, fever,
tonsillopharyngitis, cervical lymphadenopathy, leukocytosis and
hepatosplenomegaly can develop. The clinical features and a positive
heterophil test are usually sufficient to differentiate the condition from
bacterial infection and to make the diagnosis of IM [4]. Cutaneous
rash may develop during the infection. The incidence of skin eruption
in acute IM is 4.2 to 13% without drug intake [5]. By the frequent use
of antibiotics within acute IM, the incidence of skin reactions rises,
ranging between 27.8% and 69%; in some past studies for ampicillin
even 90% [1,3,6,7]. According to the literature there is no obvious
consensus on the cause of skin symptoms, whether a true drug
sensitization or only transient immunoactivation develops.
Materials and Methods
A comprehensive search was performed in PubMed database from
their inception to June 2015. The following expressions were searched
without date restriction: “antibiotic rash mononucleosis”, “infectious
mononucleosis rash”, “infectious mononucleosis exanthema”,
“epstein-barr virus infection”, amoxicillin rash viral infection” and
“infectious mononucleosis rash histopathology”. Results not strictly
related to the subject were excluded. Some of the papers were not
available to obtain due to their date, language or place of appearance.
The suitable articles were then reviewed to identify the possible
underlying mechanism of maculopapular rash in patients with
infectious mononucleosis following penicillin intake (Figure 1).
Discussion
Antibiotics: drugs causing rash with the highest incidence
within IM
There are some studies on the usefulness of antiviral, corticosteroid
and anaerobic antibacterial (metronidazole) treatments in IM,
however the generally accepted therapy is antipyretic and analgetic
drugs, enough hydration and rest [4,9-11]. The use of antibiotics is
considered mostly unnecessary and is a consequence of misdiagnosis
rather than the presence of a concomittant actual bacterial infection
[9]. Although patients suffering from IM usually present the classic
features, many of them are treated as bacterial infection. In one study
it was reported that 90.7% of IM patients were given antibiotics before
hospital admission or serology tests [12]. The incidence of skin rash is
higher in the antibiotic treated group than among patients who do not
take antibiotics [6,7]. Ampicillin was one of the first drugs which were
connected to skin eruptions in IM. However, skin rash was described
in connection with other drugs, such as penicillin G or tetracycline,
but with much lower incidence [13-15]. Later, other antibacterial
drugs were also related to skin symptoms in IM, such as amoxicillin,
talampicillin or methicillin [2, 16-18]. A few cases were reported about
cephalexin, levofloxacin, erythromycin and azithromycin [5,19-22].
More recent publications, not only case studies but clinical reports on
larger patient groups, and reviews on previously published cases,
discuss the connection between the viral infection and the antibiotic
therapy. In Tables 1 and 2 we summarize literature data on skin rash
incidence in IM in connection with various antibacterial therapies.
Figure 1: Strategy of database search.
We also included data on our patients with infectious
mononucleosis who were treated between 2002 and 2012 at the
Department of Dermatology and Allergology, University of Szeged in
Hungary [8].
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Author (s) Patel [13] Pullen et al. [52] Brown et al. [14] Timár et al. [7] Chovel-S. et al. [1]
Year 1967 1967 1967 1987 2013
Patients 38 184 150 156 238
Range of Age no statement 15-24 years university students 7 months-5 years 0-18 years
Female/Male no statement 101/83 no statement 70/86 132/106
Total rate of skin rash 42.1% (16) 35% (64) 30% (45) 33.3% (52) 30.3% (72)
Skin rash in patients treated
with antibiotics 55.6% (15/27) 45% (54/121) 33.3% (42/126) 37.7% (49/130) 32.9% (57/173)
Skin rash in patients
without antibiotics 9% (1/11) 16% (10/63) 13% (3/24) 11.5% (3/26) 23.1% (15/65)
Table 1: Studies of maculopapular rash in infectious mononucleosis.
Author (s) Patel [13] Pullen et al. [52] Brown et al. [14] Timár et al. [7] Chovel-S. et al. [1]
Year 1967 1967 1967 1987 2013
Ampicillin 100% (13/13) 95% (18/19) 69% (20/29) 83.8% (31/37) -
Amoxicillin - - - - 29.51% (18/61)
Amoxicillin+clavulanate - - - - 15.56% (7/45)
Cephalosporins - - - 83.3% (5/6) 15.38% (10/65)
Macrolides - - - 0% (0/5) 9.09% (3/33)
Penicillin - 43% - 10.2% (9/88) 8.57% 3/35)
Tetracycline - 12% (2/17) - 11.5% (3/26) -
Sulfonamid - - - 11.8% (4/34) -
Penicillin G or Tetracycline or
Sodium Cloxacillin 14% (2/14) - - - -
Table 2: Incidence of antibacterial drug induced skin rash according to antibiotic type.
An age dependent phenomenon?
Primary EBV infection appears predominantly in children,
adolescents and young adults. The infection occurring before the age
of 4 is considered to be asymptomatic or to resemble a nonspecific
viral disease, while in adolescents and adults the classical features of
the illness are prominent [1,23]. Publications on skin rash following
IM with and/or without concomitant antibiotic therapy in the age
group of few months-babies to young adults usually focus on the role
of virus-drug interaction. Only few studies discuss the possible age
related differences in the underlying pathomechanism of IM related
skin rash. Chovel-Sella et al. couldn’t find any association with the age
in the development of rash after antibiotic exposure [1]. The immune
system of a few months old child is different from an adult, which may
play an important role in the development of drug sensitization. It is
possible that true drug sensitization occurs with much lower frequency
in children, than in young adults. Further investigations are needed to
answer whether the mechanism of maculopapular eruptions following
antibiotic administration in IM differs in the different age groups.
Clinical characteristics and clinicopathologic findings in IM
related rash
As already stated, primary EBV infection occurring before the age
of 4 considered to be asymptomatic or to resemble a nonspecific viral
disease, while in adolescents and adults the previously discussed
typical symptoms develop. Mucocutaneous involvement occurs in 3%
to 15% of the patients. The skin eruptions are mostly morbilliform,
presented on the trunk, on upper extremities and on the face, after an
incubation period, usually lasting up to 7 days. Less common clinical
symptoms were also described such as erythema multiforme-like and
herpetiform lesions, urticaria, petechiae, transient cold urticaria,
immune-related thrombocytopenic purpura, erythema nodosum or
pedunculated papule on the tongue. Palatal petechiae or bilateral
upper eyelid edema can be helpful diagnostically [23-25]. Studies in
the literature report on the clinical evaluation of the skin rash and
rarely on skin biopsy.
The concomitant use of antibiotics during infectious
mononucleosis increases the occurrence of skin eruptions. In patients
taking antibiotics the eruptions usually occurs 2-10 days after starting
the antibiotic treatment [26]. The incidence ranges between 27.8% and
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69%. Chovel-Sella et al. found the aminopenicillin rash in children is
significantly lower than the 90% incidence rate reported in earlier
studies [1,3,6,7]. The skin eruptions are mostly diffuse, symmetric
maculopapular exanthems on the whole body (Figure 2). Not only
morbilliform lesions, but in some cases urticarial, purpuric and
vesicular rashes, pustular eyrthematous rash, universal erythema or
cutaneous vasculitis in the erythema multiforme pattern were also
reported in connection with antibiotic use [16,17,20,27]. Severe
cutaneous reactions such as erythema multiforme or Stevens-Johnson
syndrome may be possible manifestations [28,29]. Although these
cases are well-documented clinically, skin biopsies are rarely taken,
and histology reports are exceedingly rare. Because the clinical picture
of drug induced skin eruptions appear similar, differentiation by
histopathologic examination could be helpful [30]. We took skin
biopsies and performed histologic examinations among our patients
who developed maculopapular rash following amoxicillin intake in IM
(Figure 2). The following histopathologic changes were prominent:
hydropic degeneration of basal keratinocytes; mononuclear cells
around the vessels and a few eosinophil cells (Figure 3). Sign of
leukocytoclasia also appeared in some cases. Both the clinical and
histological features confirm a delayed type hypersensitivity reaction
[8].
Figure 2: Maculopapular rash in a patient with infectious
mononucleosis following amoxicillin intake.
Figure 3: Histolopathologic image of a patient who developed
clinically maculopapular rash after amoxicillin exposure.
Pathomechanism: maculopapular rash
Aminopenicillins may cause immediate hypersensitivity reactions
including urticarial, angioedematous or both manifestations and
anaphylaxis, however, in IM they are primarily responsible for non-
IgE-mediated reactions, such as maculopapular eruptions [31]. Drug
induced classic maculopapular drug eruptions are considered to be
delayed type hypersensitivity reactions, which involve a Th2-mediated
immune response with secretion of IL-4, IL-5 and IL-13 leading to
eosinophilic inflammatory reaction. B-cell activation and secretion of
IgE and IgG4 antibodies connects the delayed reaction to immediate
type I reaction [26,32]. Lymphocyte sensitization to β-lactams can be
demonstrated by in vivo and in vitro assays. T-cell proliferative
responses can be elicited years after the initial reaction, due to
circulating memory T-cells [33].
True hypersensitivity or transient immune reaction?
Earlier hypothesis: Previously published papers suggest that
interactions of viruses and penicillins may predispose individuals to
specific illness out-comes. It became an issue whether this
phenomenon may lead to persistent, true drug hypersensitivity or it is
just a temporary reaction [34].
In the past, in general, it was believed that the morbilliform skin
rash following antibiotic intake in patients with IM is a transient
reaction, not a true allergic reaction.
Webster et al. proposed the phenomenon to be penicillin specific.
In their in vivo and in vitro investigations they aimed to find evidence
of specific humoral or cell-mediated immune responses to ampicillin
in those patients who developed a rash following antibiotic therapy.
They suggested that ampicillin polymer-mediated lymphocyte
stimulation may play a role in the development of maculopapular rash.
Although, the polymer have weak stimulating effect on lymphocytes,
which is probably independent of previous exposure to the drug, they
showed a dose dependent widespread lymphocyte stimulation
resulting in skin eruptions with altered cell function occurring in IM
patients. Antibodies could prevent this reaction. In vivo skin testing
proved largely inconclusive, as did investigations of specific penicilloyl
antibodies [35].
McKenzie et al. stated that the phenomenon was not true penicillin
hypersensitivity, but a non-immunological reaction, because it did not
re-appear after the re-administration of the drug. After their
investigation of 20 IM (not all of them underwent previous antibiotic
therapy) and 20 control patients they concluded that the ampicillin
rash in IM resulted from a disseminated reaction of the small blood
vessels to circulating ampicillin-antibody complexes. They detected
elevated antibody-like activity against ampicillin in both IgM and IgG
immunoglobulin classes by means of a sensitive radio-immunoassay.
They proposed that the ampicillin induced antibody developed in a
similar manner to the Paul-Bunnell antibody, but it was
immunologically unrelated. These antibodies occurred without
obvious relation to prior ampicillin therapy. They suggested that
ampicillin rash could result from interaction of ampicillin with the
IgM or IgG antibody to ampicillin generated in the acute phase of
infectious mononucleosis. The rash could result as a consequence of
complement activation due to circulating antigen-antibody complexes
[36,37].
Nazareth et al. also suggested that the sensitivity to ampicillin which
develops during IM is not permanent. They applied oral drug
provocations months after the onset of skin eruptions. Untoward
effects were noted in two of the twenty patients. It was stated that this
incidence of 10% is similar to what appears in the general population
[38].
Tímár et al in Hungary investigated the occurrence of drug
exanthems among 156 children suffering from IM. There were only 3
cases out of the 26 patients receiving only symptomatic treatment who
developed maculopapular exanthems. They found that following
ampicillin or cephalexin treatment 83% of the patients developed skin
rash. Exanthems were morbilliform, maculopapular skin eruptions, all
appeared about 8 days after the start of the antibiotic therapy. The
incidence of skin reactions were less with erythromycin or
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metronidazole. Based on in vitro tests (chromatin activation of blood
lymphocytes detected by polarization microscopy and
cytophotometry) and in vivo drug provocation tests 60% of the
patients appeared to have developed drug hypersensitivity. Oral drug
provocation tests were performed in 9 of 17 individuals who had
ampicillin induced rash within IM. The patients with positive in vitro
test results proved to have true drug hypersensitization with oral
testing, while in vitro negative patients did not develop any reaction
during provocation. The authors stated that the mechanism behind
these eruptions could be due to the general, virus induced activity of
the immune system. One explanation describes the role of circulating
antibodies as a passive, anaphylactic immune reaction. After the
patient recovers from IM these heterophil antibodies disappear [7].
Current hypothesis: It is generally accepted that viral infections
enhance the risk of developing drug allergy. The underlying
mechanism is still not fully understood [34]. If within the viral
infection the antibiotic therapy induces a lasting drug specific
sensitization to the drug, that can be proved later with repeated drug
exposure. In these cases both major and minor penicillin antigen
determinants could cause the skin symptoms [7].
With changing antibiotic use physicians recognized more cases of
skin rash with other antibacterial drugs, such as levofloxacin or
azithromycin, in acute IM patients. These cases enforce the notion that
there may be no safe antibiotic to prescribe in IM. A possible
explanation of transient immune reactions may be that the virus
induces a loss of tolerance state that results in transient
hypersensitivity, in a transient Th1 lymphocyte-mediated delayed type
hypersensitivity reaction to medication. In EBV infection levels of
abnormal circulating Th1 lymphocytes are increased, leading to
activation of cell-mediated immunity. Th1 lineage mostly produce
type 2 interleukin (IL-2), interferon-gamma (INF-γ) and tumor
necrosis factor-alpha (TNF-α). IL-2 is responsible for the stimulation
of T-lymphocytes’ growth and TNF-α has pro-inflammatory effect.
INF-γ inhibits the function of Th2 lymphocytes, and their interleukin
secretion. Down-regulation of type 4 interleukin (IL-4) decreases B
lymphocytes’ growth and development. Due to the depression of type
10 interleukin (IL-10) secretion its effect on Th1-lymphocyte
suppression is absent [5,19]. Case reports, such as a case report by
Leung et al. support this concept, as some patients, similar to the one
mentioned in this particular article, can take amoxicillin again after
the previous rash without developing skin eruptions [2].
Renn et al suggested that the development of true drug
hypersensitivity allergic reaction for aminopenicillin during a florid
viral infection is definitely more prevalent as it was believed
previously. They demonstrated true sensitizations to amoxicillin in
three patients with IM. Their patients took amoxicillin during acute
IM, they showed positive proliferative responses in the lymphocyte
transformation test. In two patient side-chain-specifics sensitization
was discovered [6]. Jappe et al provided additional evidence to the
development of true delayed type hypersensitivity as well as to the
hypothesis of loss of tolerance. Eight patient with primary EBV
infection and skin eruption following aminopenicillin intake were
examined by in vivo tests. Five of them had positive patch tests to
amoxicillin and two of the five to penicillin, in addition. Two of the
five had the same reaction years after the first patch test. One patient
with positive patch test underwent oral drug challenge and had
positive response to amoxicillin and negative to cephalosporin.
Another patient of the 5 tolerated the oral penicillin challenge, thereby
revealing an isolated allergy to amoxicillin. Two patients were
completely negative with all the tests, including drug challenge, in
their cases a transient decrease in drug tolerance during EBV infection
could explain the skin symptoms [39]. We also reported evidence for
the development of true drug allergy during IM. Among our examined
ten patients lymphocyte transformation test showed negative results
with amoxicillin, while one patient had positive reaction to cefixime.
Six patients with suspected sensitization to amoxicillin were then
investigated by in vivo tests. Prick tests were negative in all six
patients, but the intradermal tests showed positive reactions in four
patients [8].
All these studies emphasize the importance of in vivo and in vitro
drug hypersensitivity examinations to verify whether true antibiotic
sensitization developed within IM. Testing is essential to decide
whether individual patients could use the suspected drug in the future
or avoidance is necessary. Based on the available clinical data it is safe
to say that even in connection with drugs different mechanisms act
behind the skin symptoms in IM.
The role of previous and/or present, acute or chronic viral infection,
in the development of drug induced reactions has received more
attention recently [40]. Molecular mimicry between amoxicillin and
viral molecules, or high affinity of betalactams for viral proteins
cannot be excluded as potential mechanisms for skin reactions in some
patients. Viral infection may be a co-activating factor for drug specific
T cells and without the acute viral infection these drug specific T cells
could apoptose, therefore we could not detect a long lasting
hypersensitivity in these patients. It is recognized that Human
Herpesvirus 6 (HHV-6), EBV and CMV reactivation appears in drug
reaction with eosinophilia and systemic symptoms (DRESS) syndrome
or in other severe cutaneous adverse drug reactions, resulting in a
marked deviation in the pathological phenotype of severe drug
eruptions [40-42]. Mardivirin et al. investigated the influence of
amoxicillin on HHV-6 replication by in vitro methods. Retrospectively
analyzed amoxicillin flare was observed in 7 patients with DRESS
syndrome induced by different drugs. They proposed that amoxicillin
induced a flare of DRESS syndrome by acting directly on herpesvirus
replication [41]. Although, in patients with acute infectious
mononucleosis the maculopapular rash always appears following the
antibiotic therapy, there may be similarities in the mechanisms by
which the virus and the drug interacts. Due to impaired drug
detoxication mechanisms (low plasma glutathione level), drug
hypersensitivity reactions are more likely to develop in patients
suffering from human immundeficiency virus (HIV) infection [43,44].
Similar mechanism, suppressed detoxification by the viral infection,
during EBV infection could also be responsible for the developing skin
reaction.
The role of in vitro investigation
Clinical history is crucial in the diagnosis of drug hypersensitivity,
but the causative drug should be verified by in vivo and in vitro allergy
examinations. In vitro tests are harmless, but they do not have 100%
sensitivity or specificity, therefore they are mostly research tools.
From the biological tests radioallergosorbent tests, immunoenzyme
assays, enzyme-linked immunosorbent assays, sepharose-
radioimmunoassays and flow cytometric basophil activation test are
used to measure serum specific IgE and detect specific surface markers
with monoclonal antibodies for evaluating immediate reactions [45].
Several in vitro assays have been used to demonstrate lymphocyte
sensitization to β-lactams. Lymphocyte transformation test (LTT) is
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considered to be a useful diagnostic tool to identify drug induced
hypersensitivity reactions. Briefly, peripheral blood mononuclear cells
from suspected sensitized individuals are exposed to the culprit drug
in order to obtain in vitro evidence of lymphocyte proliferation. The
overall sensitivity of LTT among allergic patients is found to be 62%,
although after analyzed separately, sensitivity was 64.5% for immediate
reactions and 57.9% for non-immediate immune responses. LTT
specificity was reported to be 92.8% [33,46,47].
The role if in vivo investigation
The usefulness of skin tests in the examination of drug
hypersensitivity reaction depends much on the case history and the
well-recognized clinical symptoms. In severe situations, skin testing
has to be performed with caution. In non-immediate reactions patch
tests and/or late readings of the intradermal tests after 24, 48, 72 and
96 h are recommended. Specific standardized skin test reagents are
commercially available for penicillins. These reagents, including
benzyl-penicilloyl poly-L-lysine, penicilloyl poly-L-lysine, minor
determinant mix, amoxicillin and ampicillin from a few companies,
like Allergopharma, Beecham, Antibiotic SA or Diater Laboratorios
[48-50]. Manufacturers have their own investigation protocols. In
general, examination starts by skin prick tests. If responses are
negative, intradermal, and then patch tests need to be performed.
Luque et al. found that skin tests with β-lactams were positive in 36,8%
of the patients with nonimmediate reactions [33]. Based on the
literature, delayed-reading intradermal tests appear to be slightly more
sensitive than patch tests although perhaps less specific [50]. Though
skin tests are quite useful in the diagnosis of drug allergy, if possible,
and if required, negative cutaneous tests should be confirmed by drug
provocation tests in order to prove true drug sensitization [51,52].
Conclusion
Acute infectious mononucleosis is a relatively frequent illness
among young individuals. Besides the classical clinical characteristics
generalized maculopapular eruptions may occur among these patients.
The incidence of cutaneous rash is significantly higher among patients
taking one or more antibacterial drugs during the florid viral infection.
The main viewpoint of nearly all previous literature is that an
interaction, explained by several hypotheses, exists between the drug
and the virus. However, recently published papers indicate that the
immune reaction, previously thought to be principally a transient
phenomenon, may cause persistent delayed-type hypersensitivity
reactions to antibiotics. These data underline the importance of allergy
examinations among IM patients who develop skin symptoms while
taking antibiotics.
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